TITLE

Histone deacetylase 3 as a novel therapeutic target in multiple myeloma

AUTHOR(S)
Minami, J; Suzuki, R; Mazitschek, R; Gorgun, G; Ghosh, B; Cirstea, D; Hu, Y; Mimura, N; Ohguchi, H; Cottini, F; Jakubikova, J; Munshi, N C; Haggarty, S J; Richardson, P G; Hideshima, T; Anderson, K C
PUB. DATE
March 2014
SOURCE
Leukemia (08876924);Mar2014, Vol. 28 Issue 3, p680
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Histone deacetylases (HDACs) represent novel molecular targets for the treatment of various types of cancers, including multiple myeloma (MM). Many HDAC inhibitors have already shown remarkable antitumor activities in the preclinical setting; however, their clinical utility is limited because of unfavorable toxicities associated with their broad range HDAC inhibitory effects. Isoform-selective HDAC inhibition may allow for MM cytotoxicity without attendant side effects. In this study, we demonstrated that HDAC3 knockdown and a small-molecule HDAC3 inhibitor BG45 trigger significant MM cell growth inhibition via apoptosis, evidenced by caspase and poly (ADP-ribose) polymerase cleavage. Importantly, HDAC3 inhibition downregulates phosphorylation (tyrosine 705 and serine 727) of signal transducers and activators of transcription 3 (STAT3). Neither interleukin-6 nor bone marrow stromal cells overcome this inhibitory effect of HDAC3 inhibition on phospho-STAT3 and MM cell growth. Moreover, HDAC3 inhibition also triggers hyperacetylation of STAT3, suggesting crosstalk signaling between phosphorylation and acetylation of STAT3. Importantly, inhibition of HDAC3, but not HDAC1 or 2, significantly enhances bortezomib-induced cytotoxicity. Finally, we confirm that BG45 alone and in combination with bortezomib trigger significant tumor growth inhibition in vivo in a murine xenograft model of human MM. Our results indicate that HDAC3 represents a promising therapeutic target, and validate a prototype novel HDAC3 inhibitor BG45 in MM.
ACCESSION #
94762966

 

Related Articles

  • Targeting CD137 enhances the efficacy of cetuximab. Kohrt, Holbrook E.; Colevas, A. Dimitrios; Houot, Roch; Weiskopf, Kipp; Goldstein, Matthew J.; Lund, Peder; Mueller, Antonia; Sagiv-Barfi, Idit; Marabelle, Aurelien; Lira, Ruth; Troutner, Emily; Richards, Lori; Rajapaska, Amanda; Hebb, Jonathan; Chester, Cariad; Waller, Erin; Ostashko, Anton; Wen-Kai Weng; Lieping Chen; Czerwinski, Debra // Journal of Clinical Investigation;Jun2014, Vol. 124 Issue 6, p2668 

    Treatment with cetuximab, an EGFR-targeting IgG1 mAb, results in beneficial, yet limited, clinical improvement for patients with head and neck (HN) cancer as well as colorectal cancer (CRC) patients with WT KRAS tumors. Antibody-dependent cell-mediated cytotoxicity (ADCC) by NK cells contributes...

  • Enhanced cytotoxicity of bleomycin and cisplatin after electroporation in murine colorectal carcinoma cells. Todorovic, Vesna; Sersa, Gregor; Flisar, Karel; Cemazar, Maja // Radiology & Oncology;2009, Vol. 43 Issue 4, p264 

    Background. Electrochemotherapy is a local treatment combining application of electric pulses and chemotherapy. Two chemotherapeutic drugs, bleomycin and cisplatin, have proved to be effective in electrochemotherapy. The effectiveness of electrochemotherapy was demonstrated in the treatment of...

  • Trichostatin A promotes GLI1 degradation and P21 expression in multiple myeloma cells. Geng, Yan; Liu, Jing; Xie, Ying; Jiang, Hongmei; Zuo, Kai; Li, Tao; Liu, Zhiqiang // Cancer Management & Research;Aug2018, Vol. 10, p2905 

    Background: Histone deacetylase inhibitors are promising drugs for the future application in cancer therapy. Trichostatin A (TSA), a histone deacetylase inhibitor, exhibits effective antitumor effects in various cancers. However, the effects and underlying mechanisms of TSA on multiple myeloma...

  • Dimethylamino-functionalised and N -heteroaryl-substituted titanocene anticancer drugs: synthesis and cytotoxicity studies. Thomas Hickey; James Claffey; Eoin Fitzpatrick; Megan Hogan; Clara Pampillón; Matthias Tacke // Investigational New Drugs;Oct2007, Vol. 25 Issue 5, p425 

    Summary  From the carbolithiation of 6-N,N-dimethylamino fulvene (3a) and different lithiated N-heterocyclic compounds (N,N-dimethylaminomethylpyrrole, 1-methylimidazole and 2,4-[bis(N′,N′-dimethylaminomethyl)]-N-methyl pyrrole), the corresponding lithium cyclopentadienide...

  • CD38 as a Therapeutic Target. Stevenson, George T. // Molecular Medicine;Nov/Dec2006, Vol. 12 Issue 11/12, p345 

    The CD38 molecule is well represented on cell surfaces in many cases of a variety of lymphoid tumors, notably multiple myeloma, AIDS-associated lymphomas, and post-transplant lymphoproliferations. As such, this molecule is a promising target for antibody therapy. After early disappointments,...

  • Daratumumab-225Actinium conjugate demonstrates greatly enhanced antitumor activity against experimental multiple myeloma tumors. Dawicki, Wojciech; Allen, Kevin J.H.; Jiao, Rubin; Malo, Mackenzie E.; Helal, Muath; Berger, Mark S.; Ludwig, Dale L.; Dadachova, Ekaterina // OncoImmunology;2019, Vol. 8 Issue 8, pN.PAG 

    Daratumumab is an anti-CD38 directed monoclonal antibody approved for the treatment of multiple myeloma (MM) and functions primarily via Fc-mediated effector mechanisms such as complement-dependent cytotoxicity (CDC), antibody-dependent cell cytotoxicity (ADCC), antibody-dependent cellular...

  • Phosphoproteomic analysis reveals an intrinsic pathway for the regulation of histone deacetylase 7 that controls the function of cytotoxic T lymphocytes. Navarro, Maria N; Goebel, Jurgen; Feijoo-Carnero, Carmen; Morrice, Nick; Cantrell, Doreen A // Nature Immunology;Apr2011, Vol. 12 Issue 4, p352 

    Here we report an unbiased analysis of the cytotoxic T lymphocyte (CTL) serine-threonine phosphoproteome by high-resolution mass spectrometry. We identified approximately 2,000 phosphorylations in CTLs, of which approximately 450 were controlled by T cell antigen receptor (TCR) signaling. A...

  • Effect of assay conditions on the measurement of dehydrogenase activity of Streptomyces venezuelae using triphenyl tetrazolium chloride. Burdock, Tracey; Brooks, Marianne; Ghaly, Abdel; Dave, Deepika // Advances in Bioscience & Biotechnology;Aug2011, Vol. 2 Issue 4, p214 

    Jadomycin is an antibiotic that has shown activities against bacteria, yeasts and fungi as well as cytotoxic properties to cancer cells. Because of the wide range of its inhibitory actions, jadomycin shows promise as a novel antibiotic and cancer treatment drug. Streptomyces venezuelae are...

  • Cytotoxic Effect of Ethanolic Extract Fractions of Indonesia Plant Ficus septica Burm. F. on Human Breast Cancer T47D cell lines. Nugroho, Agung Endro; Ikawati, Muthi; Hermawan, Adam; Putri, Dyaningtyas Dewi Pamungkas; Meiyanto, Edy // International Journal of Phytomedicine;2011, Vol. 3 Issue 2, p216 

    Ficus septica Burm. F. (Moraceae) is a plant which grows widely in some areas of Indonesia and other Southeast Asia countries. Previously, ethanolic extract of the plant leaves exhibit cytotoxic effect on several cell lines including T47D cells. The extract also showed chemoprevention effect in...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics